Flora Growth Corp. (FLGC)
0.46
0.00 (0.00%)
At close: Apr 14, 2025, 3:59 PM
0.00% (1D)
| Bid | 0.44 |
| Market Cap | 8.97M |
| Revenue (ttm) | 59.51M |
| Net Income (ttm) | -15.91M |
| EPS (ttm) | -1.3 |
| PE Ratio (ttm) | -0.36 |
| Forward PE | 11.29 |
| Analyst | Buy |
| Ask | 0.6 |
| Volume | 286,074 |
| Avg. Volume (20D) | 229,578.4 |
| Open | 0.48 |
| Previous Close | 0.46 |
| Day's Range | 0.45 - 0.50 |
| 52-Week Range | 0.42 - 2.11 |
| Beta | 2.01 |
About FLGC
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis derived medical and wellness products; offers skincare and beauty products; develops plant-based and medical-grade pharmaceuticals, p...
Sector Healthcare
IPO Date May 11, 2021
Employees 64
Stock Exchange NASDAQ
Ticker Symbol FLGC
Website https://www.floragrowth.com
Analyst Forecast
According to 3 analyst ratings, the average rating for FLGC stock is "Buy." The 12-month stock price forecast is $5, which is an increase of 982.95% from the latest price.
Stock ForecastsNext Earnings Release
Flora Growth Corp. is scheduled to release its earnings on May 13, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
+14.45%
Flora Growth shares are trading higher after the c...
Unlock content with
Pro Subscription
5 months ago
+10.29%
Flora Growth Corp shares are trading higher after the company announced a supply agreement with Curaleaf subsidiary Northern Green Canada. Under the agreement, Flora will be supplied with medical cannabis to distribute in the German market.
